Timothy David Osslund

This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Antibody Formulations. Top assignees: Amgen Inc., Metabolic & Atherosclerosis Research Center. Active years: 1996-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy David Osslund. Retrieved from https://idiyas.com/inventor/timothy-david-osslund

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 3)

% Patents Active = 82.4

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 8)

Average Co-Inventor Count = 1.4

ph-index = 6

Forward Citations = 207(Granted Patents)

Company Filing History:

Metabolic & Atherosclerosis Research Center

patent

where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...

Areas of Expertise:

Antibody Formulations

Cholesterol Disorders

Sclerostin

G-CSF Polypeptide

High Concentration

Crystalline Formulations

Hybrid Molecules

Keratinocyte Growth Factor

Pharmaceutical Compositions

3D Structure Expression

Analogs

Computer-Based Methods

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12534539 - METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS (2026-01-27),

2. 12178873 - High concentration antibody formulations (2024-12-31),

3. 11773184 - Crystalline antibody formulations (2023-10-03),

4. 11040102 - High concentration antibody formulations (2021-06-22),

5. 10611850 - Crystalline antibody formulations (2020-04-07),

6. 10064946 - High concentration antibody formulations (2018-09-04),

7. 9617333 - Sclerostin antibody crystals and formulations thereof (2017-04-11),

8. 9352043 - High concentration antibody formulations (2016-05-31),

9. 9145457 - Sclerostin antibody crystals and formulations thereof (2015-09-29),

10. 8058398 - Modified G-CSF polypeptide (2011-11-15),

11. 7381804 - G-CSF analog compositions and methods (2008-06-03),

12. 7276477 - Crystals of etanercept and methods of making thereof (2007-10-02),

13. 6743422 - Keratinocyte growth factor-2 products (2004-06-01),

14. 6632426 - G-CSF analog compositions and methods (2003-10-14),

15. 6261550 - G-CSF hybrid molecules and pharmaceutical compositions (2001-07-17),

Hello! I'm glad to provide you with some insights on inventor Timothy David Osslund from Camarillo, CA (US).

Title: Unveiling the Innovative Mind of Timothy David Osslund

Introduction: Timothy David Osslund is a prolific inventor based in Camarillo, CA, who has made significant contributions to the field of biopharmaceuticals.

Latest Patents:

1. *Crystalline Antibody Formulations*: Osslund's latest patent revolves around anti-PCSK9 antibody crystals, their manufacturing methods, and formulations containing these crystals.

2. *High Concentration Antibody Formulations*: Another recent patent by Osslund discloses high concentration antibody formulations comprising an anti-sclerostin immunoglobulin, an acetate salt, or an acetate buffer, along with the methods of their application.

Career Highlights: Osslund is associated with Amgen Inc., a renowned biopharmaceutical company.

Collaborations: Some of his notable coworkers include Christi L Clogston and Twinkle R Christian.

Conclusion: Timothy David Osslund's inventive spirit and groundbreaking work in developing innovative antibody formulations showcase his dedication to advancing the field of biopharmaceuticals. His collaboration with Amgen Inc. and esteemed colleagues solidifies his position as a pioneer in the industry.

Profile summary based on public USPTO records.